Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial
Sandro Pasquali, Sara Pizzamiglio, Nathan Touati, et al.
European Journal of Cancer (2019) Vol. 109, pp. 51-60
Closed Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Paolo G. Casali, N. Abecassis, Sebastian Bauer, et al.
Annals of Oncology (2018) Vol. 29, pp. iv51-iv67
Open Access | Times Cited: 1502
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, et al.
Annals of Oncology (2021) Vol. 32, Iss. 11, pp. 1348-1365
Open Access | Times Cited: 651
Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine
Adriana C. Gamboa, Alessandro Gronchi, Kenneth Cardona
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 3, pp. 200-229
Open Access | Times Cited: 416
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Journal of Clinical Oncology (2020) Vol. 38, Iss. 19, pp. 2178-2186
Open Access | Times Cited: 209
UK guidelines for the management of soft tissue sarcomas
Andrew Hayes, Ioanna Nixon, D. Strauß, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 17
Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial
Sandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Cancer (2021) Vol. 128, Iss. 1, pp. 85-93
Open Access | Times Cited: 76
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin
Valentina Fausti, Alessandro De Vita, Silvia Vanni, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1080-1080
Open Access | Times Cited: 28
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 8, pp. 898-906
Closed Access | Times Cited: 14
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
Yvonne M. Mowery, Karla V. Ballman, Angela Hong, et al.
The Lancet (2024) Vol. 404, Iss. 10467, pp. 2053-2064
Closed Access | Times Cited: 8
New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration
Winan J. van Houdt, Chandrajit P. Raut, Sylvie Bonvalot, et al.
Current Opinion in Oncology (2019) Vol. 31, Iss. 4, pp. 310-316
Open Access | Times Cited: 65
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications
Pichaya Thanindratarn, Dylan C. Dean, Scott D. Nelson, et al.
Cancer Treatment Reviews (2019) Vol. 82, pp. 101934-101934
Closed Access | Times Cited: 60
Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors
Dario Callegaro, Rosalba Miceli, Sylvie Bonvalot, et al.
EClinicalMedicine (2019) Vol. 17, pp. 100215-100215
Open Access | Times Cited: 60
SELNET clinical practice guidelines for soft tissue sarcoma and GIST
Jean‐Yves Blay, Nadia Hindi, Julien Bollard, et al.
Cancer Treatment Reviews (2021) Vol. 102, pp. 102312-102312
Open Access | Times Cited: 54
Increasing Incidence of Liposarcoma: A Population-Based Study of National Surveillance Databases, 2001–2016
Suzanne Bock, Douglas G. Hoffmann, Yi Jiang, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 8, pp. 2710-2710
Open Access | Times Cited: 52
Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)
Andrea Ferrari, Max M. van Noesel, Bernadette Brennan, et al.
The Lancet Child & Adolescent Health (2021) Vol. 5, Iss. 8, pp. 546-558
Closed Access | Times Cited: 42
Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
Andrea Ferrari, Bernadette Brennan, Michela Casanova, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 2885-2902
Open Access | Times Cited: 36
Staging Systems and Nomograms for Soft Tissue Sarcoma
Maria Danieli, Alessandro Gronchi
Current Oncology (2023) Vol. 30, Iss. 4, pp. 3648-3671
Open Access | Times Cited: 17
Myxoid Liposarcoma: How to Stage and Follow
Thanh P. Ho
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 4, pp. 292-299
Closed Access | Times Cited: 16
ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas
Isabelle Ray‐Coquard, Paolo G. Casali, Sabrina Croce, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 10, pp. 1499-1521
Open Access | Times Cited: 7
Systematic review of sarcomas radiomics studies: Bridging the gap between concepts and clinical applications?
Amandine Crombé, David Fadli, Antoîne Italiano, et al.
European Journal of Radiology (2020) Vol. 132, pp. 109283-109283
Open Access | Times Cited: 42
Recent advances in the understanding and management of liposarcoma
Candace L. Haddox, Richard F. Riedel
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 35
Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study
Marco Fiore, Silva Ljevar, Sandro Pasquali, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 3, pp. 614-620
Open Access | Times Cited: 23
Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors
Angela C. Hirbe, Carina Dehner, Eva Dombi, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 5
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers
Siyer Roohani, Jolina Handtke, Kamal Hummedah, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 1
Open Access
Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians
Anouk A. Kruiswijk, Lisa A. E. Vlug, Ibtissam Acem, et al.
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2958-2970
Open Access
Page 1 - Next Page

Scroll to top